Independent · Reader-Supported · Editorially Reviewed
§ Comparison

Compounded Tirzepatide vs Compounded Semaglutide: How To Choose

Compounded GLP-1 telehealth in 2026 isn't one product — it's two. Semaglutide (the active in Wegovy and Ozempic) and tirzepatide (the active in Zepbound and Mounjaro) are different molecules with different receptor activity, different efficacy ceilings, and different side-effect profiles. Most provider pages let you pick one without explaining the trade-offs. Here's the framework.

7 min readIndependentUpdated 2026

The Pharmacology Difference

Semaglutide is a single-receptor GLP-1 agonist. Tirzepatide is a dual GIP and GLP-1 agonist — it activates both the GLP-1 receptor that semaglutide hits and the GIP (glucose-dependent insulinotropic polypeptide) receptor that semaglutide doesn't. The dual mechanism appears to translate to greater weight loss in head-to-head data: SURMOUNT-1 (tirzepatide 15 mg) showed mean 20.9% weight loss at 72 weeks versus STEP 1 (semaglutide 2.4 mg) at 14.9% over 68 weeks.

Side-Effect Profile: Similar, But Not Identical

Both molecules cause GI side effects — nausea, diarrhea, vomiting, constipation — in the first few months of titration. In trial data, the rates are broadly comparable, with some signal that tirzepatide produces slightly more nausea and slightly less constipation. The clinical experience: most patients tolerate either one if titrated slowly; the patients who can't tolerate semaglutide sometimes do better on tirzepatide and vice versa, which is one reason flexibility between the two matters when picking a clinic.

Pricing in 2026

Compounded semaglutideCompounded tirzepatide
Typical monthly cost$199–349$329–499
Lowest entry program~$179/mo~$299/mo
Concierge tier~$449/mo~$549/mo
Typical maintenance dose1.7–2.4 mg/wk10–15 mg/wk

Tirzepatide consistently runs 30–60% more expensive than semaglutide at compounded pricing. The cost difference reflects bulk active-ingredient pricing and the relative novelty of tirzepatide compounding (semaglutide has been compounded at scale for longer).

Who Should Pick Which

  • Pick semaglutide if: you're cost-sensitive, you've tolerated it before, or you have a longer titration runway and don't need the higher efficacy ceiling.
  • Pick tirzepatide if: you have a higher BMI and want maximum efficacy, you've plateaued on semaglutide, or your insurance pathway to brand Zepbound is blocked.
  • Pick a clinic that offers both: you may want the option to switch later, and clinics that only carry one molecule lock you in.
§ Continue Reading